The Motley Fool Discussion Boards
Stocks A / Abraxis BioScience
|Subject: Abraxis Advances||Date: 11/7/2006 3:28 PM|
|Author: TMFTwitty||Number: 4 of 5|
By Brian Lawler
November 7, 2006
Nothing gets pharmaceutical investors more lathered-up than a drug developer with a so-called platform technology -- one that can be used to make existing drugs more potent, longer lasting, or safer, for example. Platform technologies are so exciting because they can potentially be applied across many already approved drugs, capturing a good chunk of an existing drug's market share. This is why investors have been so excited about Abraxis BioScience (Nasdaq: ABBI) since the approval of its cancer-treating compound, Abraxane, back in early 2005......
|Copyright 1996-2017 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us|